Co-founder/coo - Medtech Startup

**Exosome Analytics** is a MedTech startup at the forefront of liquid biopsy innovation. Our cutting-edge solutions enable rapid, non-invasive, and highly sensitive detection of disease-specific protein markers on exosomes.

Our flagship product is a groundbreaking **diagnostic tool for detection of ovarian cancer and monitoring of treatment response**, designed for use in hospitals, cancer centers, and medical laboratories. In early clinical trials, our test demonstrated **over 90% sensitivity for detecting ovarian cancer at stages I and II**—a dramatic improvement over the current standard, which achieves only ~50% sensitivity at these early stages. Importantly, our platform also detects **pre-cancerous ovarian tumors**, enabling preventive intervention.

In addition to its clinical performance, our test is **cost-effective** and **scalable**, making it an attractive option for widespread screening and post-treatment follow-up of the patients. We plan to launch the product initially as a **Research Use Only (RUO)** tool, while preparing for large-scale clinical trials to secure IVD MD Class B certification.

Our broader vision is to develop a **pan-cancer early detection platform**, and initial pilot results across other cancer types are highly promising.

**Description du poste**:
**Your Role Will Be Pivotal In**:

- Leading and optimizing **operational activities**:

- Actively contributing to **fundraising strategy and execution**:

- Driving the **launch of RUO products** (including industrialization, commercialization, regulatory filings, and client acquisition)
- Supporting the **design and coordination of clinical trials**:

- Spearheading **business development** and strategic partnerships

**Profil recherché**:
We’re seeking a driven and qualified individual to help lead the next phase of our growth. You’ll play a hands-on role in scaling our innovative diagnostics tests

Ideal Profile:

- Proven experience in a **MedTech/BioTech startup** or the **commercial arm of a healthcare company**:

- Deep understanding of the **healthcare value chain** (from R&D and labs to patients and investors)
- Solid knowledge of the **certification process** and the **French & European biomedical markets**:

- A **dual scientific/commercial background** is a strong plus
- You are **enthusiastic, mission-driven**, and ready to **commit time, knowledge, and energy** to build something impactful

**Terms of Engagement**

If you’re passionate about transforming early cancer diagnostics and want to be part of a high-impact healthtech venture, **we’d love to hear from you**.